Manufacturer record

Centurion Remedies pvt.Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

12 batches manufactured by Centurion Remedies pvt.Ltd (Gujarat) were declared Not of Standard Quality between August 2022 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

12 records linked to Centurion Remedies pvt.Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
12Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Aug 2022 to Jul 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

12
NSQ batches since 2022
11
Products affected
Assay
Most common failure
Jul 2026
Latest alert

Flagged batches per year

2022 · 32023 · 12024 · 22025 · 32026 · 3

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Alfacalcidol with Calcium Carbonate Capsules CA-3160034Mfg 2026-01 · Exp 2027-06 The sample does not conform to Manufacturer Specification with respect to the tests for Uniformity of weight and Assay of Alfacalcidol.Assay CDL, KolkataCDSCO lab Jul 2026
Vitamin B- Complex Forte Zinc Capsules. CV-1120052Mfg 2024-11 · Exp 2026-10 Sample fails in the descriptive part as per schedule V of drugs and cosmetics act and rules there under.Other RDTL, ErnakulamState lab Jun 2026
Amlodipine & Atenolol Tablets IP TH-130010Mfg 2024-11 · Exp 2027-10 The sample does not conform to the I.P. with respect to Assay of Amlodipine.Assay DTL JaipurState lab Jan 2026
Misoprostol Tablets IP 100mcg TM-1480005Mfg 2025-02 · Exp 2027-01 ContentOther Drugs Testing Laboratory, Madurai-19State lab Oct 2025
Losartan Potassium & Amlodipine Tablets IP TL-1470007Mfg 2023-12 · Exp 2026-11 The sample does not conform to the IP with respect to Assay and Dissolution.Assay DTL, JaipurState lab Oct 2025
Rifampicin, Isoniazid and Ethmbutol Hydrochloride Tablets IP TR-820008Mfg 2024-07 · Exp 2026-06 Assay of RifampicinAssay CDL KolkataCDSCO lab Apr 2025
Carbimazole Tablets IP 10 mg TC-3270005Mfg 2024-02 · Exp 2026-01 Thiamazole& other Related SubstancesRelated substances CDL KolkataCDSCO lab Nov 2024
Warfarin sodium Tablet IP 5 mg TW250004Mfg 2023-07 · Exp 2026-06 It fails the ?Description?.Description SDTL ThiruvananthapuramState lab Apr 2024
Adhesive Tape USP (Micropore Surgical Tape) R03200508Mfg 2020-03 · Exp 2025-02 Tensile strength per 2.54 cm of widthOther RDTL ChandigarhState lab Jan 2023
LEVOTHYROXINE SODIUM TABLETS IP 50 mcg TL-740003Mfg 2022-01 · Exp 2023-12 AssayAssay RDTL GuwahatiState lab Sep 2022
LEVOTHYROXINE SODIUM TABLETS IP 50 mcg TL-740003Mfg 2022-01 · Exp 2023-12 AssayAssay RDTL GuwahatiCDSCO lab Sep 2022
Primaquine Phosphate Tablets I.P. 2.5 mg. TP-980001Mfg 2020-12 · Exp 2022-11 AssayAssay RDTL GuwahatiCDSCO lab Aug 2022

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.